Syngene International has launched its Centre for Advanced Protein Studies (CAPS). The Centre has been set up in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC) at the company’s campus in Bengaluru and will host a state-of-the-art GLP accredited analytical laboratory.
CAPS will help address this challenge and will be a big boost in advancing biopharma research and product development in India. Spread across an area of 2000 sq. ft, the centre will run under the ‘Innovate in India’ program of the National Biopharma Mission, Department of Biotechnology.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
| Company Name | CMP |
|---|---|
| Syngene Internation. | 435.70 |
| Indegene | 486.80 |
| CMS Info Systems | 318.00 |
| JITF Infralogistics | 338.00 |
| Sagility | 42.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: